Study S000297

A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07055607
Acronym: PILLAR
Study type: OBSERVATIONAL
Status: ENROLLING_BY_INVITATION
Enrollment: 1250
Start: 2025-05-01
Primary completion: 2028-08-15
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1308-1428

Registered primary outcomes

Absolute change in body weight (kilograms [kg]) [From baseline (0 months) to the end of observation (24 months)]
Percentage change in body weight (percentage [%]) [From baseline (0 months) to the end of observation (24 months)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.